Doubling survival in pancreatic cancer, a long-fought rare disease approval, a massive IPO and ambitious biotech ...

One analyst applauded Trump’s order as an “official stamp of validation” for psychedelics.

Company Advances Next-generation Patented MDMA Toward Patient Dosing in 2026TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) ("PharmAla" or the ...

BioMedWire Editorial Coverage: Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how investors understand value in a sector ...

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

The Life Sciences Consulting Services Market is driven by increasing complexity in drug development and regulatory ...

Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for oncology needs AI-driven development strategy designed to significantly ...

Chinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next ...

Simulations Plus Inc (NASDAQ:SLP) is among the best medical AI stocks to buy now. On March 26, Simulations Plus announced ...

In February, a small biotech company reached a breakthrough with the FDA, agreeing to a clinical trial plan. The problem: The ...

The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...